New to the forum. in in week 4 of
A Phase 2 Study of Magrolimab Combination Therapy in Patients With Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer. She is getting Magrolimab with Drug: Sacituzumab govitecan.
Aug 2018 Diagnosed with stage three triple negative
mastectomy, possible in one lymph node Radiation with AC/Taxol chemo
July 2019 Cancer free
March 2022 massive Malignant Plural effusion, Stage 4 diagnosis with cancer restricted to sternum and left chest cavity and chest wall
Carbo Palatium Chemo - Initial worked to reduced size of cancer then started to grow again but not spread, pleural effusion did not reoccur.
Nov 2022 Started Magrolimab with Sacituzumab govitecan. clinical Trial
Is anyone currently in this trial and willing to share info?